Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hermann

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
European Journal of Pharmacology|February 5, 2013
Synthetic Aβ oligomers (Aβ(1-42) globulomer) modulate presynaptic calcium currents: prevention of Aβ-induced synaptic deficits by calcium channel blockersDavid Hermann, Mario Mezler, Michaela K Müller, et al.
The Journal of Antimicrobial Chemotherapy|February 16, 2023
Hollow-fibre system model of tuberculosis reproducibility and performance specifications for best practice in drug and combination therapy developmentTawanda Gumbo, Shashikant Srivastava, Devyani Deshpande, et al.
Antimicrobial Agents and Chemotherapy|January 31, 2022
Model-Based Meta-Analysis of Relapsing Mouse Model Studies from the Critical Path to Tuberculosis Drug Regimens Initiative DatabaseAlexander Berg, James Clary, Debra Hanna, et al.
Annals of the New York Academy of Sciences|December 9, 2024
New York State Climate Impacts Assessment Chapter 10: Water ResourcesKelsey Leonard, Stephen B Shaw, Abraham Francis, et al.
Combinatorial Chemistry & High Throughput Screening|December 12, 2012
Establishment of a secondary screening assay for P/Q-type calcium channel blockersDavid Hermann, Mario Mezler, Andrew M Swensen, et al.
Combinatorial Chemistry & High Throughput Screening|January 26, 2012
Development and validation of a fluorescence-based HTS assay for the identification of P/Q-type calcium channel blockersMario Mezler, David Hermann, Andrew M Swensen, et al.
Journal of Clinical Medicine|May 21, 2020
Epigenetic Regulation of Alternative mRNA Splicing in Dilated CardiomyopathyWeng-Tein Gi, Jan Haas, Farbod Sedaghat-Hamedani, et al.
Journal of Applied Crystallography|August 9, 2023
Extended <i>Q</i>-range small-angle neutron scattering to understand the morphology of proton-exchange membranes: the case of the functionalized syndiotactic-polystyrene model systemMaria-Maddalena Schiavone, David Hermann Lamparelli, Christophe Daniel, et al.
Plos One|March 29, 2020
The potential deployment of a pan-tuberculosis drug regimen in India: A modelling analysisNimalan Arinaminpathy, Gabriela B Gomez, Kuldeep S Sachdeva, et al.
Nature Medicine|November 16, 2018
Publisher Correction: A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosisMarjorie Z Imperial, Payam Nahid, Patrick P J Phillips, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
European Journal of Pharmacology|February 5, 2013
Synthetic Aβ oligomers (Aβ(1-42) globulomer) modulate presynaptic calcium currents: prevention of Aβ-induced synaptic deficits by calcium channel blockersDavid Hermann, Mario Mezler, Michaela K Müller, et al.
The Journal of Antimicrobial Chemotherapy|February 16, 2023
Hollow-fibre system model of tuberculosis reproducibility and performance specifications for best practice in drug and combination therapy developmentTawanda Gumbo, Shashikant Srivastava, Devyani Deshpande, et al.
Antimicrobial Agents and Chemotherapy|January 31, 2022
Model-Based Meta-Analysis of Relapsing Mouse Model Studies from the Critical Path to Tuberculosis Drug Regimens Initiative DatabaseAlexander Berg, James Clary, Debra Hanna, et al.
Annals of the New York Academy of Sciences|December 9, 2024
New York State Climate Impacts Assessment Chapter 10: Water ResourcesKelsey Leonard, Stephen B Shaw, Abraham Francis, et al.
Combinatorial Chemistry & High Throughput Screening|December 12, 2012
Establishment of a secondary screening assay for P/Q-type calcium channel blockersDavid Hermann, Mario Mezler, Andrew M Swensen, et al.
Combinatorial Chemistry & High Throughput Screening|January 26, 2012
Development and validation of a fluorescence-based HTS assay for the identification of P/Q-type calcium channel blockersMario Mezler, David Hermann, Andrew M Swensen, et al.
Journal of Clinical Medicine|May 21, 2020
Epigenetic Regulation of Alternative mRNA Splicing in Dilated CardiomyopathyWeng-Tein Gi, Jan Haas, Farbod Sedaghat-Hamedani, et al.
Journal of Applied Crystallography|August 9, 2023
Extended <i>Q</i>-range small-angle neutron scattering to understand the morphology of proton-exchange membranes: the case of the functionalized syndiotactic-polystyrene model systemMaria-Maddalena Schiavone, David Hermann Lamparelli, Christophe Daniel, et al.
Plos One|March 29, 2020
The potential deployment of a pan-tuberculosis drug regimen in India: A modelling analysisNimalan Arinaminpathy, Gabriela B Gomez, Kuldeep S Sachdeva, et al.
Nature Medicine|November 16, 2018
Publisher Correction: A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosisMarjorie Z Imperial, Payam Nahid, Patrick P J Phillips, et al.
Pageof 4